Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China
· Delayed Price · Currency is CNY 57.80
+1.27 (2.25%)
Mar 10, 2026, 3:04 PM CST
SHE:300347 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 45,976 | 43,882 | 44,807 | 87,567 | 104,196 | 139,718 | Upgrade
|
| Market Cap Growth | 5.45% | -2.06% | -48.83% | -15.96% | -25.42% | 195.17% | Upgrade
|
| Enterprise Value | 49,548 | 49,344 | 44,345 | 85,466 | 98,831 | 130,576 | Upgrade
|
| Last Close Price | 56.53 | 54.30 | 54.01 | 102.09 | 123.75 | 156.22 | Upgrade
|
| PE Ratio | 79.16 | 108.31 | 22.13 | 43.64 | 36.25 | 79.85 | Upgrade
|
| Forward PE | 56.52 | 28.29 | 19.90 | 32.89 | 48.60 | 111.97 | Upgrade
|
| PS Ratio | 7.01 | 6.65 | 6.07 | 12.36 | 19.99 | 43.77 | Upgrade
|
| PB Ratio | 1.86 | 1.82 | 1.83 | 3.86 | 5.06 | 7.82 | Upgrade
|
| P/TBV Ratio | 2.65 | 2.57 | 2.50 | 5.23 | 6.47 | 9.61 | Upgrade
|
| P/FCF Ratio | 45.72 | 59.27 | 53.55 | 96.34 | 98.75 | 165.90 | Upgrade
|
| P/OCF Ratio | 36.55 | 40.00 | 38.95 | 64.51 | 73.18 | 139.90 | Upgrade
|
| PEG Ratio | 5.81 | 3.69 | 1.20 | 1.89 | 3.81 | 3.88 | Upgrade
|
| EV/Sales Ratio | 7.55 | 7.47 | 6.01 | 12.06 | 18.96 | 40.90 | Upgrade
|
| EV/EBITDA Ratio | 58.91 | 40.62 | 23.64 | 44.48 | 67.77 | 136.22 | Upgrade
|
| EV/EBIT Ratio | 98.74 | 48.88 | 26.23 | 48.48 | 73.55 | 148.61 | Upgrade
|
| EV/FCF Ratio | 49.27 | 66.64 | 53.00 | 94.03 | 93.66 | 155.05 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.12 | 0.14 | 0.12 | 0.05 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 2.08 | 2.12 | 1.68 | 1.34 | 0.64 | 0.32 | Upgrade
|
| Debt / FCF Ratio | 1.74 | 3.83 | 4.00 | 2.99 | 0.92 | 0.39 | Upgrade
|
| Net Debt / Equity Ratio | 0.00 | 0.03 | -0.17 | -0.23 | -0.37 | -0.55 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.06 | 0.57 | -2.22 | -2.69 | -5.21 | -10.24 | Upgrade
|
| Net Debt / FCF Ratio | 0.04 | 0.93 | -4.97 | -5.68 | -7.20 | -11.66 | Upgrade
|
| Asset Turnover | 0.22 | 0.23 | 0.26 | 0.28 | 0.24 | 0.24 | Upgrade
|
| Inventory Turnover | 145.81 | 157.49 | 199.06 | 302.27 | 544.16 | 566.25 | Upgrade
|
| Quick Ratio | 2.08 | 1.68 | 2.72 | 2.95 | 4.46 | 10.17 | Upgrade
|
| Current Ratio | 2.16 | 1.72 | 2.74 | 2.98 | 4.50 | 10.22 | Upgrade
|
| Return on Equity (ROE) | 2.59% | 1.85% | 9.12% | 10.50% | 17.64% | 17.36% | Upgrade
|
| Return on Assets (ROA) | 1.06% | 2.16% | 3.70% | 4.30% | 3.88% | 4.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.61% | 3.02% | 7.72% | 10.15% | 11.76% | 12.89% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.90% | 4.00% | 6.60% | 7.40% | 6.30% | 4.80% | Upgrade
|
| Earnings Yield | 1.33% | 0.92% | 4.52% | 2.29% | 2.76% | 1.25% | Upgrade
|
| FCF Yield | 2.19% | 1.69% | 1.87% | 1.04% | 1.01% | 0.60% | Upgrade
|
| Dividend Yield | 0.52% | 0.55% | 1.05% | 0.54% | 0.40% | 0.19% | Upgrade
|
| Payout Ratio | 61.16% | 158.50% | 29.13% | 24.52% | 9.89% | 15.50% | Upgrade
|
| Buyback Yield / Dilution | 0.83% | 0.22% | 0.07% | 0.62% | -9.01% | -7.27% | Upgrade
|
| Total Shareholder Return | 1.35% | 0.77% | 1.12% | 1.16% | -8.60% | -7.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.